home / stock / lly / lly news


LLY News and Press, Eli Lilly and Company From 05/31/24

Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...

LLY - Catalyst Watch: Nvidia stock split buzz, COMPUTEX, Walmart's annual meeting, and REITs on display

2024-05-31 15:00:19 ET More on the markets Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight Hedge funds back at record exposure to Magnificent 7 S&am...

LLY - US Companies Moving the Markets, Morning edition
Fri, May 31, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 8.6% to $0.0384 on volume of 89,961,220 shares Nuburu Inc. (BURU) rose 29.4% to $0.207 on volume of 85,213,370 shares Novo Integrated Sciences Inc. (NVOS) rose 139.5% to $1.08 on volume ...

LLY - Summit pares gains as 'China-only' trial beats Merck's Keytruda

2024-05-31 08:59:26 ET More on Akeso, Merck, etc. Merck Stock: Still Discounted To Graham P/E Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Merck: The Worst Has Been Avoided (Rating Upgrade) Dividend Roundup: Meta Platfo...

LLY - A Better Way To Crash The GLP-1 Party

2024-05-30 16:10:00 ET Summary The global market for GLP-1 therapies now looks on pace to top $100 billion. GLP-1 pioneers such as Eli Lilly, Novo Nordisk, could be joined by new players Amgen, Altimmune, Pfizer, Viking, Roche, and privately held Boehringer Ingelheim that have GLP...

LLY - Goldman Sachs raises obesity drug market estimate to $130B

2024-05-30 11:22:06 ET More on Eli Lilly, Novo, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Lilly's Retevmo gains appro...

LLY - Stocks with momentum and at least 5% EPS revisions since end of March - Wolfe Research

2024-05-29 14:13:00 ET More on S&P 500 Index: A Tale Of Two Indices 2024 Election: What We Think For Markets 'True' Inflation Is Higher Than The 'Official' Numbers Dow -1%, S&P and Nasdaq slip as airlines, health insurers weigh; Treasurys extend fall ...

LLY - Lilly's Retevmo gains approval for children as young as two with thyroid cancer

2024-05-29 12:32:44 ET More on Eli Lilly Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Ro provides supply tracking fea...

LLY - Ro provides supply tracking feature for Lilly, Novo Nordisk weight loss drugs

2024-05-29 12:11:20 ET More on Eli Lilly, Novo Nordisk Eli Lilly: Addressing Supply Challenges Should Accelerate Growth SA Asks: Is Eli Lilly or Novo Nordisk a better investment? Novo Nordisk: The Market Is Right, Don't Fight Against It SA Asks: Who...

LLY - Harding Loevner International Equity ADR Composite Q1 2024 Report

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

LLY - Harding Loevner International Equity Composite Q1 2024 Report

2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

Previous 10 Next 10